Frey Annette

Frey Annette, a woman-owned small business sole proprietorship based in New York, provides medical case review and expert analysis services for federal vaccine injury and countermeasures compensation programs as a prime contractor under total small business set-asides. The vendor competes exclusively under the total small business set-aside category across its entire federal footprint and operates as a solo practitioner, with no subcontract engagement.

Frey Annette's customer concentration is absolute: all 60 awards, representing $15.3 million in combined potential value, fund work for the Department of Health and Human Services' Health Resources and Services Administration Headquarters. The vendor specializes in detailed examination of medical records and case files to determine eligibility for federal compensation under HRSA's Vaccine Injury Compensation Program (VICP) and Countermeasures Injury Compensation Program (CICP). Work is performed in New York, with firm fixed-price task orders typically ranging from $12,500 to $25,000 per call. Recent representative task orders include a $50,000 ceiling medical case reviewer call awarded September 2, 2026, with completion by August 1, 2027; a $25,000 VICP medical expert services call awarded August 13, 2026, with completion by July 12, 2027; and a $25,000 VICP medical expert services call awarded July 30, 2026, with completion by June 29, 2027. All task orders are designated total small business set-asides under firm fixed-price pricing.

Frey Annette holds four active BPAs with HRSA Headquarters. The primary vehicle is a $7.5 million single-award BPA established May 8, 2024, running through May 7, 2029, which has issued 22 task orders carrying $283 thousand in combined potential value. Three earlier BPAs—awards from 2019, an unnamed vehicle with 12 task orders ($250 thousand), and a 2024 vehicle with 12 task orders ($306 thousand)—remain active with legacy task orders. Recent activity has remained modest—five awards in 2026 against four in 2025—though the 2024 establishment of the $7.5 million BPA anchor provides multi-year stability. Five awards with ultimate completion dates in the next twenty-four months carry combined potential value of $150 thousand. The vendor has maintained a continuous presence with HRSA dating to at least 2010, with SAM.gov registration since January 2010, establishing fifteen-plus years of sole-source reliance on VICP and CICP case review work.